Researchers from Wageningen University & Research and Van Andel Institute used a variant of CRISPR, a gene-editing tool, to ...

The MarketWatch News Department was not involved in the creation of this content.-- Precede Bio Insight debuts as a first-of-its-kind product enabling genome-wide inference of gen ...

By Karen Roman SkylineDx said it can predict metastases and outperform existing staging systems for the country’s second most common type of skin cancer, Cutaneous Squamous Cell Carcinoma (CSCC). The ...

SkylineDx, an innovative company specializing in molecular diagnostics for dermatology, today announced the latest research on the company's precision molecular diagnostics advances, including a new ...

GeneCentric, a company making precision medicine more precise by bringing gene expression biology to liquid biopsy, today announced that it will present three posters at the American Association for ...

A new study from Karolinska Institutet shows that gene analysis of breast cancer tumors can identify patients who do not ...

Translocations are chromosomal “cut and paste” errors that drive many lymphomas, a type of blood cancer and the sixth most common form of cancer overall. This includes mantle cell lymphoma, a rare but ...

Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...

Rutgers University researchers find that certain aging immune T cells can blunt cell expansion and may help explain why many ...

(This April 1 Health Rounds has been corrected to change ‘genetic’ to ‘genomic’ in the headline and the first item of the ...